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The spike (S) protein of a nonfusogenic murine coronavirus, MHV-2, was compared to the S protein of a variant with
fusion activity, MHV-2f. Two amino acids differed between the S proteins of these viruses; one was located in the signal
sequence and the other was in the putative cleavage site. The amino acid at position 12 in the signal sequence was S in
MHV-2 and C in MHV-2f. The amino acid sequence of the cleavage site of MHV-2 was HRARS, while that of MHV-2f was
HRARR, showing one amino acid replacement at position 757. In DBT cells infected with MHV-2, the S protein was not
cleaved, while the S protein of MHV-2f was cleaved. The S protein of MHV-2f expressed in a transient vaccinia virus
expression system was cleaved and was fusogenic in contrast to the nonfusogenic activity of uncleaved MHV-2 S protein.
Because the signal sequence is assumed to be removed from the mature S protein soon after synthesis, and because the
S protein of MHV-2 was expressed on the cell surface in the same way as the S protein of MHV-2f, the difference in the
signal sequence seemed to have had little effect on the transportation and the fusion activity of the S protein. These results
showed that MHV-2 does not fuse cells due to the lack of cleavage of its S protein. This conclusion differs from studies
on the activity of syncytium formation by the S proteins of fusogenic MHV-JHM and -A59 strains. Possible reasons for
these differences in fusion activity are discussed. q 1997 Academic Press
Murine coronavirus (MHV) is an enveloped virus with though these fusion peptides characteristically have a
single-stranded, positive-sense genomic RNA of about hydrophobic amino acid cluster, such a cluster is not
31 kb (1–4). The spike (S) protein of MHV is a transmem- found in the N terminus of the membrane-anchored S2
brane glycoprotein of about 180 kDa and is cleaved by subunit of coronavirus S protein (8). Studies of mutants
trypsin-like enzymes that are derived from the host cell MHV-JHMV and -A59 and an MHV-A59 variant, whose S
into two 90-kDa subunits (5). The N-terminal S1 subunit proteins were not cleaved due to amino acid replace-
forms the bulbous head and the C-terminal S2 subunit ments in the cleavage site, suggested that cleavage of
is anchored in the virion envelope (4). The S protein the S protein may not be a prerequisite for syncytium
mediates attachment to cells and induces syncytium in formation, although it facilitates that activity (9–12).
fusogenic MHV strains (5, 6). Whether or not S protein Most MHV strains produce cell-to-cell fusion on cul-
cleavage is required for syncytium formation is still con- tured DBT cells forming syncytia. MHV-2 is the only strain
troversial. The treatment with exogenous protease en- which does not induce syncytia (13, 14). However, we
hanced syncytium formation by MHV (5) and the treat- noticed that fusion-type MHV-2 variants were present in
ment with protease inhibitors causes a delay in the onset our MHV-2 stock virus and we isolated a fusion-type
of fusion (7). These data suggested that the cleavage of MHV-2 variant by plaque purification. We compared fu-
the S protein may be important for fusion activity in much sion-negative MHV-2 and its fusion-positive variant with
the same way that protein cleavage acts in other fuso- respect to cleavage of the S protein and transportation
genic viruses, such as orthomyxoviruses, paramyxovi- of the S protein to the cell surface. These comparisons
ruses, and retroviruses; in those viruses, cleavage of the suggested that fusion activity of the MHV-2 depends
surface glycoprotein exposes the fusion peptide on the upon cleavage of its S protein.
N terminus of the membrane-anchored subunit (8). Al- A fusion-positive variant of MHV-2 was obtained using
plaque cloning. About 3–51 104 PFU of the MHV-2 stock
virus were layered on DBT cells growing in a 15-cm dish,
The nucleotide sequence data reported in this article have been and the cells were cultured for 12 to 18 hr. The plaquesdeposited with the GenBank Database under Accession No. U72635.
with syncytium formation were visually distinguished1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /81-425-65-3315; E-mail: ykyamada@nih.go.jp. from the cells infected with nonfusogenic MHV-2. Ap-
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FIG. 1. Immunofluorescent staining of DBT cells infected with MHV-2 or -2f. Viral antigens were detected with rat anti-MHV-2 antiserum and
FITC-conjugated anti-rat IgG (MBL, Nagoya) after fixation with chilled acetone. (A) 7 hr p.i. with MHV-2f. (B) 24 hr p.i. with MHV-2. (C) Uninfected
DBT cells.
proximately 1 plaque of 1–2 1 106 parental plaques were mixed with 2.5 U Takara Ex Taq (Takara Biochemi-
cals), 0.25 mM each dATP, dCTP, dTTP, and dGTPshowed a fusion-type plaque. The fusion-type plaques
were isolated and plaque-purified three times. The final (dNTPs), and 0.2 mM each sense primer, 5*-CGCAAG-
CTTCTAAACATGCTATTCGTGT-3* [the MHV-2 S geneplaque-purified isolate was designated MHV-2f. By using
a panel of monoclonal antibodies against the S protein around the initiation codon (17) and its attached HindIII
site], and complementary primer, 5*-CGGGATCCAGGA-of JHMV, we confirmed that MHV-2f was closely related
to parental MHV-2 and was not a fusion-type contaminant GAGGCTGTGATAGTCA-3* [the S gene around the stop
codon (18) and its attached BamHI site], in a total volumefrom another MHV strain (data not shown).
To compare cytopathic effects and virus growth, DBT of 50 ml Ex Taq buffer. The mixture was amplified for 30
cycles of denaturation at 947 for 0.5 min, annealing atcells were inoculated with MHV-2 or -2f at a multiplicity
of 1 to 3. Virus titers in the culture fluids were deter- 607 for 1 min, and elongation at 727 for 3.5 min, and
the amplified samples were electrophoresed on a 0.5%mined by plaque assay as previously reported (15). No
substantial difference in the growth of these viruses agarose gel. Bands of about 4 kb were clearly amplified
from MHV-2 and -2f, and were purified from agarosewas observed. The progeny viruses were detected from
6 hr postinfection (p.i.) after which their titers increased gel by the Prep-A-Gene DNA purification kit (Bio-Rad).
Sequence analysis of PCR products was performed bygradually, reaching a plateau at 12 hr p.i. to 0.8 – 3 1
107 PFU/ml (data not shown). Infected cells were also a dideoxy termination labeling method according to the
manufacturer’s instructions (Applied Biosystems; Modelobserved for cytopathic effect and expression of viral
antigen. At 7 hr p.i., syncytium formation was observed, 373A-18 DNA sequencing system). Sequencing oligonu-
cleotide primers were synthesized to fit every 300 to 400and viral antigen was detected in the cytoplasm in
MHV-2f-infected cells (Fig. 1A). In contrast, parental bases of the MHV-2 S gene in both directions of genomic
and complementary sense. The deduced amino acid se-MHV-2 had not induced syncytia by 24 hr, although viral
antigen was detected in the cytoplasm of infected cells quence of MHV-2 showed that the MHV-2 S protein was
composed of 1361 amino acids. The length of the S gene(Fig. 1B). Viral antigen was not detected in uninfected
DBT cells (Fig. 1C). is assumed to vary among the MHV strains. In MHV-
JHMV, several types are reported; JHMV cl-2 is knownThe S protein is responsible for syncytium formation
of MHV infected cells (5, 6, 9–12); therefore, we com- to have a long S gene (18). The amino acid sequence of
MHV-2 was compared with the published amino acidpared the amino acid sequences of the S proteins of
nonfusogenic MHV-2 and fusogenic MHV-2f. The full- sequence of JHMV cl-2 (schematically shown in Fig. 2).
Fifteen amino acids were deleted from the correspondinglength coding region of the S protein was amplified using
PCR. At 16 hr p.i., total cellular RNA was extracted from region of cl-2. Among these deleted amino acids, 12
amino acids were located in a hypervariable region inthe infected DBT cells and 10 mg of RNA was reverse
transcribed into cDNA using oligo(dT) as a primer, as the S1 subunit where a nucleotide deletion occurs in
many MHV strains (19, 20). Three additional amino acidsdescribed previously (16). The cDNA transcripts (5 ml)
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data showed that the difference in the fusogenicity of
MHV-2 and -2f depended on the S protein.
The first amino acid replacement was located in the
signal sequence, which is reported to be composed of
20 amino acids from the N terminus of the S protein and
to be removed from the S protein soon after synthesis
(22). A possibility exists that the amino acid difference
in the signal sequence can influence the transportation
of the S protein to the cell surface. To determine the cell-
surface expression of the MHV-2 S protein, live mono-
layers of MHV-2- and -2f-infected cells were reacted with
S protein-specific monoclonal antibody at 47 for 1 hr,
followed by FITC-labeled anti-mouse Ig’s (TAGO). Granu-
lar positive dots were detected on the cell surface at 7
and 24 hr after MHV-2 infection, and by 7 hr after MHV-
FIG. 2. Diagrammatic representation of the deletion site in the MHV- 2f infection a wide granularly stained area appeared in
2 S gene. The sequences of JHMV cl-2, JHMV (Ds141), and A59 were the syncytium, demonstrating that both S proteins were
cited from published data (18, 23, 22). The deletion is indicated by thin transported to the cell surface (data not shown).
lines.
The second amino acid replacement was located in
the putative cleavage site. This mutation could influence
the cleavage of the S protein, since a host cell-derivedwere deleted from the S2 subunit. The overall S gene-
sequence homology between MHV-2 and cl-2 was proteolytic enzyme is reported to recognize the amino
acid sequence RRARR in this position for JHMV and82.23%, excluding the deleted sequence. Comparison of
the nucleotide sequences of MHV-2 and -2f revealed only
2 nucleotide replacements (35, C to G and 2271, C to A).
Both of these changes led to the replacement of the
predicted amino acids. One was the 12th amino acid
from the initiation codon which is located in the signal
sequence (Fig. 3). The amino acid at position 12 in MHV-
2 was S and in MHV-2f was C. The other replacement
was located in the basic amino acid cluster of the cleav-
age site (Fig. 3). The amino acid at position 757 was S in
MHV-2 and R in MHV-2f. To compare these two positions
among various MHV strains, DNA fragments including
the signal sequence region and the putative cleavage
site were amplified. Sequence analysis of the PCR prod-
uct showed that MHV-2 had unique amino acids at posi-
FIG. 3. Comparison of predicted amino acid sequences around thetions 12 and 757 and that MHV-2f had the same se-
signal sequence and the putative cleavage site. Nucleotide sequences
quences as the other fusogenic MHV strains in both were analyzed by RT-PCR from total cellular RNA of DBT cells infected
positions (Fig. 3). with MHV-2, -2f, -JHMV, -A59, -1, -3, -S, -NuU, and -D. The cDNA tran-
scripts (5 ml) of various MHV strains were mixed with 0.6 U Taq DNATo demonstrate the role of the S protein of MHV-2f in
polymerase (Perkin Elmer Cetus), 0.2 mM each dNTP in a total volumesyncytium formation, full-length S genes of MHV-2 and -2f
of 50 ml reaction buffer. To amplify the signal sequence, 0.5 mM eachwere transiently expressed in a vaccinia virus expression
sense primer, 5*-TATAAGAGTGATTGGCGTCC-3* [1–20 of leader se-
system (21). DBT cells were infected with a recombinant quence (26)], and anti-sense primer, 5*-ACAGGGTAATAACCAGTAAG-
vaccinia virus encoding bacteriophage T7 RNA polymer- 3* (193–212 of the MHV-2 S gene), were added in reaction mixture.
To amplify the putative cleavage site sequence, sense primer, 5*-CCA-ase (vTF7-3, kindly provided by Dr. B. H. Moss), and then
GCGCTACTATATCG-3* (2065–2081 of the MHV-2 S gene), and anti-5 mg of pGEM4Z plasmids (Promega) harboring the MHV-
sense primer, 5*-GACTCAACACTATCATT-3* (2329–2345), were added2 or -2f S gene in the HindIII and BamHI sites were
for MHV-S or sense primer, 5*-GGTTGTGTTGTTAATGCTGA-3* (2161–
transfected with a DOTAP transfection reagent (Boeh- 2180), and anti-sense primer, 5*-TACTCAACCAACTGCTG-3* (2482–
ringer Mannheim). At 16 hr posttransfection, syncytium 2498), for other strains. After initial heating at 947 for 4 min, amplification
was performed for 30 cycles of denaturation at 947 for 1 min, annealingformation was observed in cells transfected with the
at 557 for 1.5 min, and elongation at 727 for 2 min followed by finalMHV-2f S gene. On the other hand, syncytium formation
extension at 727 for 5 min. The amplified samples were electrophoresedwas not detected in cells transfected with the MHV-2
on a 1% agarose gel and purified. Sequence analysis was performed
S gene, even though the expression of S protein was as mentioned in the text using both directions of primers. The number
detectable by immunofluorescent staining with S protein- is based on the amino acid sequence of MHV-2. The arrow shows the
putative cleavage site.specific monoclonal antibody (data not shown). These
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of serine with arginine at position 757 appeared to influ-
ence the cleavage of the S protein. As expected, the
MHV-2f S protein was cleaved, in contrast to the cleav-
age resistance of nonfusogenic MHV-2 S protein. The
other mutation at position 12 was located in the signal
sequence that is considered to be removed from the
mature S protein soon after synthesis. Transportation of
the S protein to the cell surface was detectable in both
MHV-2- and -2f-infected cells, indicating that this muta-
tion in the signal sequence had little effect on transporta-
FIG. 4. Western blot analysis of S proteins. (A) DBT cells grown in tion. These results allowed us to conclude that MHV-2f
12-well plates were infected with MHV-2, -2f, and cl-2. (B) DBT cells
acquired the ability to form syncytia because of its abilitywere infected with vTF7-3 and transfected with plasmid pGEM4Z har-
to cleave the S protein. This does not rule out the possi-boring the MHV-2 or -2f S genes. After 16-hr incubation, cells were
washed with PBS and lysed with 100 ml of PBS containing 1% Nonidet- bility, however, that the replacement at position 12 might
P40. The lysed samples were centrifuged at 15,000 rpm for 10 min at have some effect on fusion activity. Point mutation analy-
47 and the supernatants were collected. The lysates were boiled in a sis should show whether the mutation at position 12
sample buffer and electrophoresed in a 7.5% SDS–polyacrylamide gel.
affects syncytium formation by MHV-2f.Western blotting analysis of the lysates was carried out as described
In addition to the putative trypsin cleavage site of thepreviously (27), using S2 subunit-specific monoclonal antibody and
horseradish peroxidase-conjugated anti-mouse Ig’s (TAGO). The bands S protein, three regions of the S protein are involved in
were visualized with PBS containing 0.05% diaminobenzidine and fusion activity of MHV. One is the hypervariable region
0.015% hydrogen peroxide. of the S1 subunit (24). The transmembrane region (12)
and a predicted heptad repeat region of the S2 subunit
(25) are also proposed to influence the fusion activity.RRAHR for A59 (23, 22). To determine whether the S
proteins of MHV-2 and -2f are cleaved, we performed These regions were identical in fusogenic MHV-2f and
nonfusogenic MHV-2, and therefore are unlikely to haveWestern blotting analysis using cell lysates infected with
MHV-2, -2f, and JHMV cl-2 (Fig. 4A). Cell lysates collected affected the fusogenic activities of MHV-2 and -2f.
In fusogenic strains JHMV and A59, cleavage of the S18 hr p.i. were used in Western blotting, and the S protein
was detected with S2-specific monoclonal antibody protein is not absolutely required, because the S proteins
of these viruses with mutations in the putative cleavage(kindly provided by Dr. S. Siddell). Two major bands at
150 and 180 kDa were detected in the lysate of MHV- site can induce syncytium, yet are not cleaved (9–12).
We describe here that the S protein of MHV-2 failed to2-infected cells. The 150-kDa protein may represent a
nonglycosylated form of the mature 180-kDa protein that induce fusion due to a lack of cleavage. Perhaps the S
proteins of fusogenic MHV strains induce fusion withoutis observed in the MHV-A59 S protein (12). In contrast,
the 150- and 90-kDa bands were detected in the lysates cleavage of the S protein. In contrast, the MHV-2 S pro-
tein required cleavage for activation of its fusion ability.of MHV-2f- and JHMV cl-2-infected cells. Most of the
mature 180-kDa S protein was cleaved to S1 and S2 Cleavage of the MHV-2 S protein may alter its conforma-
tion thereby activating the otherwise nonfusogenic char-subunits which were detected as the 90-kDa band. In
MHV-2-infected cells, a 90-kDa band was not detected, acter of this protein. Such a process would be very simi-
lar to that of other fusogenic orthomyxo-, paramyxo-, andrevealing that the MHV-2 S protein was not cleaved. Faint
bands were seen just above the location of the S2 band retroviruses (8). In these viruses, the newly appearing
hydrophobic N terminal region of the membrane-an-in MHV-2-, -2f-, and cl-2-infected cells; these bands prob-
ably do not represent S protein cleavage products, be- chored subunit is postulated to work as a fusion peptide.
In the N terminus of the MHV-2 S2 subunit, however, acause they are absent from the S proteins expressed in
the vaccinia virus system, as shown in Fig. 4B. These similar fusion peptide with a stretch of apolar amino
acids, containing mainly alanine and glycine, was notresults showed that the replacement of amino acid 757
changed the cleavability of the MHV-2 S protein. found. We speculated that the region affecting fusion
activity is possibly located inside S2, as is postulated forWe have investigated differences between nonfuso-
genic MHV-2 and its fusogenic variant MHV-2f, looking Semliki Forest, Sindbis, and Rous sarcoma viruses (8),
because fusion activity is thought not to reside in the Nspecifically at differences in fusion activity and in the
characteristics of the S protein, which is known to medi- terminus of the MHV S protein (14). The hypothesis that
the MHV-2 S protein is inactive with respect to fusionate fusion in MHV. Sequence analysis showed that two
amino acids at positions 12 and 757 from the N terminus and that the S proteins of A59 and JHMV are actively
fusogenic without cleavage could be tested by using chi-of the S protein differed between the two viruses. The
mutation found at position 757 was located at the putative meric S proteins. Fusion chimeras of the S protein could
also help identify the region responsible for fusion activitycleavage site, which is reported to be digested with a
trypsin-like host cell-derived enzyme. The replacement on the S protein.
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